Amova Asset Management Americas, Inc. filed Amendment No. 3 to a Schedule 13G with the SEC on November 12, 2026, disclosing beneficial ownership of 1,689,107 shares of Arcturus Therapeutics Holdings Inc common stock as of September 30, 2026.

Key Highlights

  • Beneficial ownership: Amova Asset Management Americas, Inc. reported aggregate beneficial ownership of 1,689,107 shares of Arcturus Therapeutics Holdings Inc common stock.
  • Percent of class: The 1,689,107 shares represent 5.9% of the class, according to the filing.
  • Shared voting power: The firm reported shared voting power over 1,459,991 shares, with sole voting power of 0.
  • Shared dispositive power: Shared dispositive power covers all 1,689,107 shares, with sole dispositive power of 0.
  • Triggering event date: The date of event requiring this filing was September 30, 2026.
  • Filer type: The reporting person is classified as an investment adviser (IA), incorporated in the United States.

Amova Asset Management Americas Discloses 5.9% Position as of September 30, 2026

According to the filing, Amova Asset Management Americas, Inc., headquartered at 605 Third Avenue, 38th Floor, New York, NY 10158, submitted Amendment No. 3 to Schedule 13G covering shares of Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT), whose common stock carries a par value of $0.001 per share and CUSIP number 03969T109. The issuer's principal executive offices are listed at 10285 Science Center Drive, San Diego, CA 92121.

The filing reports that as of September 30, 2026, Amova Asset Management Americas, Inc. beneficially owned 1,689,107 shares, representing 5.9% of the class. The firm reported zero sole voting power and zero sole dispositive power over any of the shares. Shared voting power was reported over 1,459,991 shares, while shared dispositive power extended to the full 1,689,107 shares. The filing notes that additional detail regarding ownership on behalf of another person is provided in Exhibit A of the filing.

The document was signed on November 12, 2026 by Gary L. Beckham, Chief Compliance Officer of Amova Asset Management Americas, Inc. The certification included in the filing states that "the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities."

What Was Disclosed

Amova Asset Management Americas, Inc. filed Amendment No. 3 to Schedule 13G on November 12, 2026, reporting beneficial ownership of 1,689,107 shares, or 5.9%, of Arcturus Therapeutics Holdings Inc common stock as of September 30, 2026, with all dispositive power held on a shared basis.